Archer Investment Corporation’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Archer Investment Corporation’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.37K	Hold	248	–	–	﹤0.01%	852
2026 Q1	$7.2K	Hold	248	–	–	﹤0.01%	859
2025 Q4	$6.5K	Hold	248	–	–	﹤0.01%	815
2025 Q3	$5.86K	Hold	248	–	–	﹤0.01%	825
2025 Q2	$5.09K	Hold	248	–	–	﹤0.01%	839
2025 Q1	$5.08K	Hold	248	–	–	﹤0.01%	815
2024 Q4	$5.61K	Hold	248	–	–	﹤0.01%	808
2024 Q3	$6.1K	Hold	248	–	–	﹤0.01%	771
2024 Q2	$5.73K	Hold	248	–	–	﹤0.01%	761
2024 Q1	$5.97K	Hold	248	–	–	﹤0.01%	743
2023 Q4	$5.71K	Hold	248	–	–	﹤0.01%	762
2023 Q3	$5.05K	Sell	248 -752	-75%	-$16.9K	﹤0.01%	747
2023 Q2	$23.4K	Hold	1,000	–	–	0.01%	485
2023 Q1	$23.3K	Hold	1,000	–	–	0.01%	465
2022 Q4	$25.2K	Hold	1,000	–	–	0.01%	438
2022 Q3	$26.4K	Hold	1,000	–	–	0.01%	420
2022 Q2	$28.9K	Hold	1,000	–	–	0.01%	416
2022 Q1	$33.8K	Hold	1,000	–	–	0.01%	410
2021 Q4	$43.8K	Hold	1,000	–	–	0.01%	383
2021 Q3	$50.7K	Hold	1,000	–	–	0.02%	356
2021 Q2	$52K	Hold	1,000	–	–	0.02%	322
2021 Q1	$45.7K	Sell	1,000 -6,000	-86%	-$293K	0.02%	355
2020 Q4	$322K	Hold	7,000	–	–	0.15%	150
2020 Q3	$273K	Hold	7,000	–	–	0.14%	144
2020 Q2	$266K	Sell	7,000 -2,000	-22%	-$67.5K	0.15%	139
2020 Q1	$242K	Buy	+9,000	New	+$256K	0.16%	139

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Archer Investment Corporation's IDNA Position: Q2 2026 in Review

Archer Investment Corporation held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 248 shares worth $8.37K. The position accounts for ﹤0.01% of the portfolio, ranked #852.

Archer Investment Corporation first reported a position in IDNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $322K in Q4 2020. 65 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Archer Investment Corporation held 248 shares of iShares Genomics Immunology and Healthcare ETF worth $8.37K as of Q2 2026.
Archer Investment Corporation left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #852 holding.
Archer Investment Corporation first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2020 and has held it in 26 quarters since.
Archer Investment Corporation's iShares Genomics Immunology and Healthcare ETF position peaked at $322K in Q4 2020.
65 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.